TherapeuticsMD Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD (TXMD) Misses Q2 EPS by 1c
August 4, 2016 5:11 PM EDTTherapeuticsMD (NYSE: TXMD) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $5.63 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More